Login / Signup

Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.

Debora de Melo GagliatoTomás ReinertCláudio RochaMonique Celeste TavaresSâmio PimentelWilliam FuzitaMárcia AraújoDanielli MatiasSabina AleixoBruno FrançaÉrida MagatonNatália BritoAna Carolina Ferreira CardosoVivienne Carduz Castilho
Published in: Oncology and therapy (2024)
NCT03892655.
Keyphrases
  • early stage
  • epidermal growth factor receptor
  • metastatic breast cancer